Supplier News

Aug 22, 2017
By Pharmaceutical Technology Editors
The private equity funding will enable the startup biotech firm to expand product development as well as sales and marketing capabilities.
Aug 22, 2017
By Pharmaceutical Technology Editors
CDMO Micro-Sphere is investing CHF 21 million (approximately $21.63 million) into the expansion of its GMP manufacturing capabilities at its Swiss facility.
Aug 21, 2017
By Pharmaceutical Technology Editors
Sartorius Stedim Biotech presents a new system for laboratories needing low volumes of ultrapure water.
Aug 16, 2017
By Pharmaceutical Technology Editors
The $12-million acquisition will strengthen Cancer Genetics Inc.’s (CGI) capabilities in drug discovery, drug development, and early phase clinical trial testing in the field of oncology.
Aug 15, 2017
By Pharmaceutical Technology Editors
Lonza announced an endothelial cell application center, which expands Lonza’s support for researchers.
Aug 15, 2017
By Pharmaceutical Technology Editors
The MDL15 combustible dust air-vac from Vac-U-Max is part of the company’s industrial vacuum cleaning product range for combustible dusts and offers high-volume cleanup of powders and combustible dusts.
Aug 14, 2017
By Pharmaceutical Technology Editors
The expansion at its Lincolnshire, IL, facility will double the footprint of the site’s range of services, including microbiological evaluation, drug stability studies, and medical devices testing.
Aug 10, 2017
By Pharmaceutical Technology Editors
The acquisition adds sterile manufacturing capability to the CDMO’s services, which include API formulation and manufacturing.
Aug 10, 2017
By Pharmaceutical Technology Editors
Cambrex is investing $24 Million in new, highly potent API manufacturing capacity at its Charles City, Iowa site.
Aug 07, 2017
By Pharmaceutical Technology Editors
Charles River Labs has announced the acquisition of Brains On-Line (US), a contract research organization (CRO) that provides data on therapeutics for treating central nervous system (CNS) diseases.
native1_300x100
lorem ipsum